Pharmaceuticals Legal News Coverage

Daily Business Review

Galvano Raises Concerns on Governor's Drug Importation Plan

By Christine Sexton | February 25, 2019

Senate President Bill Galvano told reporters he is on board with portions of the governor's plan that involve the possibility of buying drugs from Canada for Medicaid and prison health care.

3 minute read

The Legal Intelligencer

Allentown Pharma Company Agrees to Pay $4M Penalty for Allegedly Dodging FDA Fees

By P.J. D'Annunzio | February 22, 2019

Lehigh Valley Technologies, an Allentown-based pharmaceutical company, has entered into a $4 million agreement with the government to settle claims that it schemed to avoid paying certain FDA fees, Philadelphia-area U.S. Attorney William McSwain announced Friday.

3 minute read

The Legal Intelligencer

McKesson Asks US Judge to Toss Out Shingles Vaccine Cases

By Max Mitchell | February 22, 2019

McKesson, which is facing claims that it misrepresented the vaccine's safety, filed a motion to dismiss Thursday in the U.S. District Court for the Eastern District of Pennsylvania, contending that 92 cases should be dismissed because the complaints failed to give sufficient details about the allegations.

3 minute read

Litigation Daily

McKesson Asks Federal Judge in Philadelphia to Toss Shingles Vaccine Cases

By Max Mitchell | February 22, 2019

McKesson, which is facing claims that it misrepresented the vaccine's safety, filed a motion to dismiss Thursday in the U.S. District Court for the Eastern District of Pennsylvania, contending that 92 cases should be dismissed because the complaints failed to give sufficient details about the allegations.

3 minute read

New Jersey Law Journal

Lawsuits Over Contaminated Drug Valsartan Consolidated in Camden

By Charles Toutant | February 21, 2019

The suits were granted mass tort status after an investigation by the Food and Drug Administration found the drug contained trace amounts of a probable human carcinogen.

5 minute read

The Legal Intelligencer

Eli Lilly GC: Multidistrict Litigation Needs Intensive Care

By Michael J. Harrington | February 21, 2019

Many of the law suits prominent in today's headlines—the ones concerning opioids, talc, NFL concussions and many pharmaceutical products—are part of a 50-year-old experiment in legal procedure known as multidistrict litigation whose vital signs are now flashing an immediate need for intensive care.

6 minute read

Daily Report Online

Eli Lilly GC Quotes Georgia Judge in Criticism of Multidistrict Litigation

By Michael J. Harrington | February 21, 2019

Many of the lawsuits prominent in today's headlines—the ones concerning opioids, talc, NFL concussions and many pharmaceutical products—are part of a 50-year-old experiment in legal procedure known as multidistrict litigation whose vital signs are now flashing an immediate need for intensive care.

6 minute read

Corporate Counsel

Multidistrict Litigation Needs Intensive Care

By Michael J. Harrington | February 21, 2019

Many of the law suits prominent in today's headlines—the ones concerning opioids, talc, NFL concussions and many pharmaceutical products—are part of a 50-year-old experiment in legal procedure known as multidistrict litigation whose vital signs are now flashing an immediate need for intensive care.

6 minute read

Connecticut Law Tribune

Eli Lilly GC: Reforms Needed to Save Multidistrict Litigation

By Michael J. Harrington | February 21, 2019

Many of the law suits prominent in today's headlines—the ones concerning opioids, talc, NFL concussions and many pharmaceutical products—are part of a 50-year-old experiment in legal procedure known as multidistrict litigation whose vital signs are now flashing an immediate need for intensive care.

6 minute read